SCHEMBL4157944

SCHEMBL4157944

CSc1ccc(N(C)C(=O)NC(=O)c2c(F)cccc2F)c(C(F)(F)F)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RORC P51449 2/20 0.40
TRPA1 O75762 3/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 2/20 0.35
PKM P14618 1/20 0.35
CYP1A2 P05177 1/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPK1 P28482 1/20 0.35
TLR7 Q9NYK1 3/20 0.34
IL2 P60568 2/20 0.34
PPIA P62937 1/20 0.34
USP2 O75604 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TLR8 Q9NR97 3/20 0.33
STIM1 Q13586 1/20 0.33
ORAI1 Q96D31 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4154199 0.87 RAB9A (0.38) RORCNPC1RAB9APKMKDM4E
SCHEMBL4154615 0.81 RORC (0.43) RORCKDM4EALDH1A1TLR7
SCHEMBL4154082 0.80 RORC (0.43) RORCRAB9APKMTLR7PPIA
SCHEMBL4158996 0.80 TRPA1 (0.34) RORCTRPA1NPC1RAB9APKM
SCHEMBL4908707 0.78 IL2 (0.44) RORCTRPA1CYP1A2ALDH1A1TLR7
SCHEMBL4150976 0.78 MEN1 (0.39) RORCRAB9ATLR7IL2USP2
SCHEMBL4150857 0.78 RORC (0.36) RORCTRPA1RAB9ACYP1A2ALDH1A1
SCHEMBL4151007 0.78 TRPA1 (0.33) RORCTRPA1NPC1RAB9APKM
SCHEMBL4160195 0.77 TRPA1 (0.35) RORCTRPA1NPC1RAB9ACYP1A2
SCHEMBL13774542 0.76 TRPA1 (0.32) RORCTRPA1NPC1RAB9APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 RORC 4448/4885TRPA1 268/4885NPC1 1869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.